Xu Yan-Song, Zhao Bo, Long Chen-Yan, Li Hui, Lu Xing, Liu Gang, Tang Xiao-Zhun, Tang Wei-Zhong
Department of Emergency, First Affiliated Hospital, Guangxi Medical University, Nanning, China E-mail :
Asian Pac J Cancer Prev. 2014;15(11):4563-6. doi: 10.7314/apjcp.2014.15.11.4563.
To evaluate relationship between the cyclooxygenase-2 promoter 765G/C polymorphism and digestive cancer risk in China.
A literature search through February 2014 was performed using PubMed, Chinese Biomedical Literature Database (CBM) and China National Knowledge Infrastructure (CNKI) databases, and a meta-analysis was performed with RevMan 5.2 software for odds ratios and 95%CIs.
In total, 9 articles with 3,263 cases and 4,858 controls were included in this meta-analysis.The pooled OR (95%CIs) in the co-dominant model (GC vs GG) was 1.56 [1.19, 2.06], and in the dominant model ((CC+GC) vs GG), the pooled OR was 1.59 [1.21, 2.09] in overall cancers. In the subgroup analysis, stratified by cancer type, significant associations were found that the-765C allele had increased pancreatic cancer and gastric risk. No significant liver cancer and colorectal cancer risk of COX-2 -765G/C polymorphism was found.
These findings suggest that COX-2-765*C is related to cancer susceptibility and may increase gastric and pancreatic cancer risk.
评估中国人群中环氧合酶-2(COX-2)启动子765G/C多态性与消化系统癌症风险之间的关系。
通过检索PubMed、中国生物医学文献数据库(CBM)和中国知网(CNKI)数据库,纳入截至2014年2月的相关文献,并使用RevMan 5.2软件进行荟萃分析,计算比值比(OR)及95%可信区间(CI)。
本荟萃分析共纳入9篇文献,包含3263例病例和4858例对照。在共显性模型(GC vs GG)中,总体癌症的合并OR(95%CI)为1.56 [1.19, 2.06];在显性模型((CC + GC) vs GG)中,合并OR为1.59 [1.21, 2.09]。亚组分析按癌症类型分层后发现,-765C等位基因与胰腺癌和胃癌风险增加显著相关。未发现COX-2 -765G/C多态性与肝癌和结直肠癌风险存在显著关联。
这些研究结果表明,COX-2 -765*C与癌症易感性相关,可能增加胃癌和胰腺癌风险。